Perspectives on Healthcare and Investment
VITA Continental actively engages with the healthcare ecosystem as healthcare investors, sector participants, and long-term partners to growth-stage businesses. Through articles, podcast conversations, and selected events, we share informed perspectives on the medical device market, private investment trends, and the forces shaping healthcare innovation.
Videos & Podcast
Private Capital Meets Healthcare Expertise
Analysis of healthcare market developments, private investment activity, regulatory change, and the structural trends shaping European medical device companies. Practical insight for investors, founders, and industry decision-makers.
Meet the Partners
Marco Fumagalli has dedicated his entire career to private equity, with a sustained focus on the healthcare sector. He spent fourteen years as a Global Partner and CEO of the Italian Division at 3i Group, one of Europe’s leading private equity firms, where he managed investments in both private and publicly listed healthcare companies, including Vis Pharmaceuticals, Newron, and Novuspharma.
As the founder of Continental Investment Partners and a Partner at VITA Continental, Marco has active responsibility for new investments and portfolio management.
Carlo Sgarbi spent more than 20 years in investment banking at Banca IMI, the investment banking arm of Intesa Sanpaolo Group, working across Global Markets, DCM, and M&A before becoming CEO and CIO of a major Swiss family office. During this period, he also founded a regulated asset management company and led a £55 million IPO on the London Stock Exchange’s AIM market. In 2013, he co-founded Continental Investment Partners with Marco Fumagalli.
As Managing Partner of Continental Investment Partners and Founding Partner at VITA Continental, Carlo leads investor relations and fundraising activities across the platform.
Stefano Alfonsi has dedicated his entire career to leading MedTech companies at the highest level. Beginning at Johnson & Johnson/DePuy, where he rose to Worldwide Vice President of Marketing, before assuming a series of CEO mandates that have defined his standing in the industry. At LimaCorporate, he grew revenue from €50 million to €117 million. At Corin Group, he scaled the business from €50 million to €200 million over eight years through four strategic acquisitions. He subsequently served as CEO of Aleva Neurotherapeutics and, most recently, Elos Medtech, where he was appointed Chairman of the Board in 2021 before serving as President and CEO from 2022 to 2025.
As a Partner at VITA Continental, he focuses particularly on MedTech founders and management teams.
Marcello Nesta began his career at a corporate finance advisory firm, raising debt and equity capital for SMEs across a range of sectors. In 2017, he joined Continental Investment Partners as an Investment Manager. Since then, he has worked closely with portfolio companies, serving as CFO and a board member at RanD, AlfaMed, and Keros Digital, and as President of Happy Friends until its successful exit to Arcaplanet.
As a Partner at VITA Continental, Marcello leads new investments and portfolio management across the platform.